S
096530
vs
GILD
GILD
Over the past 12 months, Seegene Inc has underperformed GILD, delivering a return of +11% compared to the GILD's +49% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
GILD
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Seegene Inc
KOSDAQ:096530
|
27 100
KRW
|
|||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
146.29
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
096530, GILD
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Seegene Inc
Revenue
|
|||||||||||
|
Gilead Sciences Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
096530, GILD
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Seegene Inc
KOSDAQ:096530
|
|||||||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Seegene Inc | ||||
|
Gilead Sciences Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
096530, GILD
Performance Gap
096530, GILD
Performance By Year
096530, GILD
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.